GSK tops quarterly expectations, consumer arm spin off on track

British drugmaker GSK on Wednesday beat analyst expectations for its first-quarter profit and sales, ahead of the planned listing of its large consumer healthcare division in July, and stood by its forecasts for 2022.

Also Read: British PM and finance minister to be fined over lockdown parties